Apellis Pharmaceuticals to Host Conference Call on July 31, 2025, to Discuss Second Quarter 2025 Financial Results

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced it will host a conference call and webcast to discuss its second quarter 2025 financial results on Thursday, July 31, 2025, at 8:30 a.m. ET.

Investors can pre-register for the call, and a live audio webcast with accompanying slides will be available through the company's website. The webcast replay will be accessible for 90 days after the event.

News Market Reaction

+0.95%

1 alert

+0.95% News Effect

On the day this news was published, APLS gained 0.95%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WALTHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its second quarter 2025 financial results on Thursday, July 31, 2025, at 8:30 a.m. ET.

To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for 90 days following the event.

About Apellis 
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on Twitter and LinkedIn.

Investor Contact:
Neil Carnahan
neil.carnahan@apellis.com
617.977.5703

FAQ

When is Apellis Pharmaceuticals (APLS) Q2 2025 earnings call?

Apellis Pharmaceuticals will host its Q2 2025 earnings call on Thursday, July 31, 2025, at 8:30 a.m. ET.

How can investors access the Apellis Pharmaceuticals Q2 2025 earnings call?

Investors can access the call by pre-registering online or viewing the live audio webcast through the 'Events and Presentations' page on Apellis' website.

How long will the Apellis Q2 2025 earnings call replay be available?

The webcast replay will be available for 90 days following the event.

What does Apellis Pharmaceuticals (APLS) specialize in?

Apellis is a global biopharmaceutical company that developed the first new class of complement medicine in 15 years, with two approved medicines targeting C3, including the first therapy for geographic atrophy.